Matthew Duffy, Director at CorMedix Inc. (CRMD), sold 30,000 shares at $6.48 ($194K) on 2015-06-04, disclosed to the SEC on 2015-06-04.
Open-market sale of $194k CRMD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.